Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
VVOS
VVOS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VVOS News
Vivos Partners with SoundHealth to Launch Innovative Sleep Solutions
Feb 05 2026
Newsfilter
Oversold Stocks in Healthcare Sector Present Buying Opportunities
Feb 03 2026
Benzinga
Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M
Jan 20 2026
Globenewswire
Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding
Jan 16 2026
seekingalpha
Vivos Therapeutics CEO and CFO to Discuss Strategic Business Model on December 16, 2025
Dec 15 2025
Globenewswire
Vivos Therapeutics Hosts Strategic Discussion on OSA Market Opportunities
Dec 15 2025
Newsfilter
Vivos Therapeutics Sees Major Revenue Increase in Q3 2025
Nov 19 2025
Newsfilter
Alto Neuroscience Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Monday
Nov 17 2025
Benzinga
Biotech Surge on Friday: Clinical Advancements Drive Afternoon Gains
Sep 29 2025
NASDAQ.COM
Vivos Therapeutics Introduces Innovative Model
Aug 19 2025
NASDAQ.COM
Vivos Therapeutics Announces Financial Results for Q2 2025 and Offers Operational Update
Aug 19 2025
Newsfilter
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth
Jul 30 2025
Newsfilter
VOR Skyrockets On Ex-China Rights To Autoimmune Drug, ADIL To Face FDA On Jul.29, PSTV Jumps 14%
Jun 26 2025
NASDAQ.COM
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
Jun 26 2025
Newsfilter
Vivos Therapeutics Finalizes Acquisition Of The Sleep Center Of Nevada
Jun 11 2025
NASDAQ.COM
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
Jun 11 2025
Newsfilter
Show More News
